PI3K and CDK4/6 Strategies: Efficacy Data and Management of Toxicity
0% Complete
Course Content
This material is non-CME, no credits are available, and a certificate will not be provided upon completion.
Course Details
- Duration
- 0.00 hour
- Released
- May 14, 2025
- Last Review
- May 14, 2025
- Expires
- May 14, 2028
Faculty & Disclosure
Faculty
Mohammad Jahanzeb, MD
Disclosure
Mohammad Jahanzeb, MD discloses no such relationships exist
Accreditation
NA
Related Courses
2026 NOSCM | We Should Change Treatment Based on Emerging Mutations in Patients with ER+/HER2- Metastatic Breast Cancer (NO)
0.00 Credits
1 Chapter
Breast
Free
2026 NOSCM | We Should Change Treatment Based on Emerging Mutations in Patients with ER+/HER2- Metastatic Breast Cancer (YES)
0.00 Credits
1 Chapter
Breast
Free